Relationship of99mtechnetium labelled macroaggregated albumin (99mTc-MAA) uptake by colorectal liver metastases to response following selective internal radiation therapy (SIRT) 7

BMC Nuclear Medicine

Volumn 5, Issue , 2005, Pages

  Dhabuwala, Atul ^a   Lamerton, Prue ^a   Stubbs, Richard S ^a  

^a Wakefield Hospital   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; MACROSALB TC 99M; YTTRIUM 90;

ADULT; AGED; ARTICLE; CALCULATION; CANCER RADIOTHERAPY; CLASSIFICATION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG UPTAKE; FEMALE; HEPATIC ARTERY; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; QUALITATIVE ANALYSIS; RETROSPECTIVE STUDY; SELECTIVE INTERNAL RADIATION THERAPY; TREATMENT OUTCOME;

EID: 32044475100     PISSN: 14712385     EISSN: 14712385     Source Type: Journal    
DOI: 10.1186/1471-2385-5-7     Document Type: Article

References (21)

1. Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M, Fenoglio-Preiser CM, Napier J, Horne CHW, Lopez MJ, Shaw-Dunn RI, Sugar J, Davies JD, Day DW, Harlos JP: Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986, 150:195-203.
2. Stubbs RS, Cannan RJ, Mitchell AW: Selective Internal Radiation Therapy with 90Yttrium Microspheres for Extensive Colorectal Liver Metastases. J Gastrointest Surg 2001, 5(3):294-302.
3. Gray B, van Hazel G, Buck M, Paton G, Burton M, Anderson J: Treatment of colorectal liver metastases with SIR-spheres plus chemotherapy. GI Cancer 2000, 3:249 -2457.
4. Taylor I, Bennett R, Sherriff S: The blood supply of colorectal liver metastases. Br J Cancer 1979, 39:749-756.
5. Lau WY, Ho S, Leung TW, Chan M, Ho R, Johnson PJ, Li AK: Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90Yttrium microspheres. Int J Radiation Oncol Biol Phys 1998, 40(3):583-592.
6. Gray B, van Hazel G, Hope M, Burton M, Moroz P, Paton G, Anderson J: Randomised trial of SIR- Spheres® plus chemotherapy versus chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001, 12:1711-1720.
7. Stubbs RS, Cannan R: Selective internal radiation therapy with 90Yttrium microspheres for primary or metastatic cancer confined to the liver. In Multi-treatment modalities of liver tumours Edited by: Nagy A Habib. New York , Kluwer Academic/Plenum Publishers; 2002:305-321.
8. Daly JM, Butler J, Kemeny N, Yeh SD, Ridge JA, Botet J, Bading JR, DeCosse JJ, Benua RS: Predicting tumour response in patients with colorectal hepatic metastases. Ann Surg 1985, 202(3):384-393.
9. Kemeny N, Niedzwiecki D, Shurgot B, Oderman P: Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. Cancer 1989, 63(4):742-747.
10. Civalleri D, Scopinaro G, Balletto N, Claudiani F, DeCian F, Camerini G, DePaoli M, Bonalumi U: Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres. Br J Surg 1989, 76(7):699-703.
11. Lehner B, Kretzschmar U, Bubeck B, Hölting T, Schlag P: Results of liver angiography and perfusion scintigrapy do not correlate with response to hepatic artery infusion chemotherapy. J Surg Oncol 1988, 39(2):73-78.
12. Leung TW, Lau WY, Ho SK, Ward SC, Chow JH, Chan MS, Metreweli C, Johnson PJ, Li AK: Radiation pneumonitis after selective internal radiation treatment with intraarterial 90Yttrium-microspheres for inoperable hepatic tumours. Int J Radiation Oncol Biol Phys 1995, 33(4):919-924.
13. Stubbs RS, Cannan RJ, Mitchell AW, Alwan MH: An initial experience with selective internal radiation therapy (SIRT) for non-resectable colorectal liver metastases. GI Cancer 1999, 3(2):135-143.
14. Andrews JC, Walker SC, Ackermann RJ, Cotton LA, Ensminger WD, Shapiro B: Hepatic radioembolization with Yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 1994, 35(10):1637-1644.
15. Dancey JE, Shepherd FA, Paul K, Sniderman KW, Houle S, Gabrys J, Hendler AL, Goin JE: Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med 2000, 41(10):1673-1681.
16. Carr BI: Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004, 10(2 Suppl 1):S107-110.
17. Leung WT, Lau WY, Ho SK, Chan M, Leung NW, Lin J, Metreweli C, Johnson PJ, Li AK: Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial Technitium-99m macroaggregated albumin. J Nucl Med 1994, 35(1):70-73.
18. Grady ED: Internal radiation therapy of hepatic cancer. Dis Colon Rectum 1979, 22(6):371-375.
19. Mantravadi RV, Spigos DG, Tan WS, Felix EL: Intraarterial Yttrium 90 in the treatment of hepatic malignancy. Radiology 1982, 142(3):783-786.
20. Kim DK, Watson RC, Pahnke LD, Fortner JG: Tumor vascularity as a prognostic factor for hepatic tumors. Ann Surg 1977, 185(1):31-34.
21. Goldberg JA, Murray T, Kerr DJ, Willmott N, Bessent RG, McKillop JH, McArdle CS: The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intraheptic tumour. Br J Cancer 1991, 63(2):308-310.